Accuray (ARAY) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
9 Jul, 2026Executive summary
Achieved record Q4 revenue of $134.3M, up 14% year-over-year, driven by strong international demand and record system shipments, despite ongoing U.S. market weakness.
International markets contributed over 80% of annual revenue, with significant growth in China, APAC, and EIMEA, offsetting a 26% decline in Americas revenue.
Strategic milestones included regulatory approvals in China and Europe, new product launches, and expansion into emerging markets like India and Japan.
Service contract revenue grew 4.5% year-over-year, reflecting a growing installed base and pricing actions.
Entered FY 2025 with a $487M backlog, representing over two years of product revenue potential.
Financial highlights
Q4 net revenue: $134.3M (+14% YoY); full-year revenue: $446.6M (flat YoY).
Q4 product revenue: $79.7M (+28% YoY); 36 system shipments, a company record.
Q4 service revenue: $54.6M (-2% YoY); full-year service revenue: $212.4M (-1% YoY).
Q4 gross margin: 28.6% (down from 31.9% YoY), impacted by China margin deferral and supplier quality issue.
Q4 operating income: $6.8M (vs. -$0.5M prior year); Q4 adjusted EBITDA: $10.1M (vs. $5.2M YoY); FY24 adjusted EBITDA: $19.7M (down from $23.9M YoY).
Outlook and guidance
FY 2025 revenue guidance: $460M–$470M; adjusted EBITDA: $27.5M–$29.5M.
Guidance assumes U.S. market recovery in H2 FY 2025 and China margin deferral release starting Q2.
Expects 3–5% top-line growth and >40% EBITDA margin for FY 2025.
Projected FY25 GAAP net loss: $3M–$5M.
Monitoring U.S. and China market conditions, including anti-corruption and stimulus impacts.
Latest events from Accuray
- Stockholders to vote on $55M recapitalization, share increase, and reverse split to support transformation.ARAY
Proxy filing - Registration enables resale of 6.8M shares from warrants linked to recent financing.ARAY
Registration filing - Q3 FY26 revenue fell 7% and guidance was withdrawn amid geopolitical and macro headwinds.ARAY
Q3 2026 - Shelf registration covers resale of 7M shares from warrants tied to recent financing.ARAY
Registration Filing - Revenue and margin guidance cut as China headwinds, tariffs, and financing changes weigh.ARAY
Q2 2026 - FY2025 guidance raised as China growth and service gains offset margin and revenue declines.ARAY
Q1 2025 - Growth driven by innovation, emerging markets, and margin expansion, with U.S. recovery expected.ARAY
Jefferies Global Healthcare Conference - Q3 FY25 revenue up 12%, net loss narrowed, but guidance cut on tariffs; EBITDA improved.ARAY
Q3 2025 - Q2 revenue up 8% to $116.2M, net income $2.5M, margin 36.1%, guidance raised.ARAY
Q2 2025